David A. Ford - 05 Mar 2025 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Reporting relationship: Chief People Officer
Issuer ticker: PRTA
Reported as of: 05 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Mar 2025, 16:24:16 UTC
Prior SEC filing: 05 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Michael J. Malecek, as Attorney-in-Fact for David A. Ford

Key filing fact

David A. Ford filed Form 4 for PROTHENA CORP PUBLIC LTD CO (PRTA) on 07 Mar 2025.

Key facts

This page summarizes David A. Ford's Form 4 filing for PROTHENA CORP PUBLIC LTD CO (PRTA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Mar 2025, 16:24.

Change

Previous filing in this sequence was filed on 05 Mar 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRTA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +107,500
Change %
Price: $0.000000
Shares after: 107,500
Date: 05 Mar 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 107,500
Exercise price: $14.95
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 5, 2026, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.